175.50
-0.50
(-0.28%)
At close: 1:30:09 PM GMT+8
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Po-Ching Lee | Financial Manager | -- | -- | -- |
Ever Supreme Bio Technology Co., Ltd
No. 30, Keya Road
4th Floor Daya District
Taichung
Taiwan
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Ever Supreme Bio Technology Co., Ltd engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells. Its products include UMC01, a drug candidate in Phase I clinical trials for the treatment of myocardial infarction and stroke; ADCV01, a drug candidate in Phase II clinical trials for the treatment of malignant brain tumor; CAR001, a chimeric antigen receptor immune cells product; and bone-marrow stem cells (BMSC), used to treat chronic stroke, degenerative osteoarthritis, and spinal cord injuries. The company was incorporated in 2016 and is based in Taichung, Taiwan.
Corporate Governance
Ever Supreme Bio Technology Co., Ltd’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
May 29, 2024 at 12:00 AM UTC
Ex-Dividend Date
Related Tickers
4162.TWO PharmaEngine, Inc.
95.10
+2.15%
4743.TWO Oneness Biotech Co., Ltd.
79.70
+1.66%
6589.TWO EirGenix Inc.
79.80
+1.01%
4147.TWO TaiMed Biologics Inc.
86.50
+0.35%
6535.TWO Lumosa Therapeutics Co., Ltd.
263.50
-0.57%
6550.TW Polaris Group
43.40
+0.46%
4726.TWO Mycenax Biotech Inc.
40.25
0.00%
4174.TWO OBI Pharma, Inc.
56.90
+1.25%
6733.TWO BioGend Therapeutics Co., Ltd.
33.00
0.00%
6919.TW CALIWAY BIOPHARMACEUTICALS CO L
665.00
+3.74%